0.8070
27-November-24 10:29:00
15 minutes delayed
Stocks
+0.0320
+4.13%
Today's range
0.7890 - 0.8070
ISIN
FR0010557264
Source
Cboe
AB Science announces that a new independent publication confirms the role of masitinib as a potential therapy in neurodegenerative disorders including Alzheimer's Disease
08 Mar 2021 01:02:16 By Nasdaq GlobeNewswire
AB Science announces that a new independent publication confirms the role of masitinib as a potential therapy in pancreatic cancer
23 Feb 2021 01:02:09 By Nasdaq GlobeNewswire
AB Science announces that a new independent publication confirms that masitinib has anti-vital activity against the SARS-CoV-2 virus in vitro and is a promising candidate for treating Covid-19
25 Jan 2021 01:26:50 By Nasdaq GlobeNewswire